Federal contract award
36C25224C0034
SHAHRARA HUMANIZED MONOCLONAL ANTIBODY FOR SYNDECAN TWIST BIOSCIENCE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | 252-NETWORK CONTRACT OFFICE 12 (36C252) |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $104.6K |
| Current contract value | $104.6K |
| Potential contract value / ceiling | $150.0K |
| Start date | Sep 18, 2024 |
| Current end date | Sep 14, 2025 |
| Potential end date | Sep 14, 2025 |
| Latest award activity | Aug 26, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 26, 2026 | P00001 | $-45.4K | CONTRACT CLLOSEOUT |
| Aug 19, 2024 | 0 | $150.0K | SHAHRARA HUMANIZED MONOCLONAL ANTIBODY FOR SYNDECAN TWIST BIOSCIENCE |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.